|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 267.50 SEK | 0.00% |
|
+1.52% | +21.32% |
| 09-25 | Danske Bank resumes coverage of Medicover with a buy rating and a target price of SEK 314 - BN | FW |
| 09-23 | Medicover replaces two members of the nomination committee | FW |
Company Valuation: Medicover AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,394 | 1,870 | 2,021 | 2,515 | 3,079 | 3,649 | - | - |
| Change | - | -65.34% | 8.07% | 24.48% | 22.41% | 18.5% | - | - |
| Enterprise Value (EV) 1 | 5,884 | 2,761 | 2,965 | 3,674 | 4,436 | 4,425 | 4,433 | 4,457 |
| Change | - | -53.08% | 7.39% | 23.92% | 20.75% | -0.25% | 0.17% | 0.55% |
| P/E | 52.7x | 155x | 114x | 150x | 39.8x | 38.9x | 28.9x | 23.2x |
| PBR | 10.6x | 4.01x | 4.18x | 5.53x | 5.78x | 4.85x | 4.35x | 3.86x |
| PEG | - | -1.8x | 2.5x | -29.5x | 0x | 1.9x | 0.8x | 0.9x |
| Capitalization / Revenue | 3.92x | 1.24x | 1.16x | 1.2x | 1.29x | 1.44x | 1.33x | 1.2x |
| EV / Revenue | 4.27x | 1.83x | 1.7x | 1.76x | 1.87x | 1.75x | 1.62x | 1.46x |
| EV / EBITDA | 21.8x | 12.7x | 12.2x | 12.9x | 12x | 10.7x | 9.5x | 8.33x |
| EV / EBIT | 36.9x | 49.7x | 48.3x | 52.3x | 28.5x | 23.1x | 19.4x | 16.4x |
| EV / FCF | 51.4x | 93.3x | 31.4x | 26.3x | 205x | 28.8x | 24x | 20x |
| FCF Yield | 1.95% | 1.07% | 3.19% | 3.8% | 0.49% | 3.47% | 4.16% | 5% |
| Dividend per Share 2 | 0.12 | 0.12 | 0.12 | 0.15 | 0.2 | 0.2228 | 0.2808 | 0.3471 |
| Rate of return | 0.33% | 0.96% | 0.89% | 0.9% | 0.98% | 0.93% | 1.17% | 1.45% |
| EPS 2 | 0.686 | 0.081 | 0.118 | 0.112 | 0.513 | 0.6175 | 0.8319 | 1.036 |
| Distribution rate | 17.5% | 148% | 102% | 134% | 39% | 36.1% | 33.8% | 33.5% |
| Net sales 1 | 1,377 | 1,510 | 1,746 | 2,092 | 2,378 | 2,530 | 2,743 | 3,053 |
| EBITDA 1 | 270.4 | 217.4 | 243.8 | 284.9 | 371 | 414 | 466.8 | 535.3 |
| EBIT 1 | 159.4 | 55.5 | 61.4 | 70.3 | 155.7 | 191.5 | 228.9 | 272.5 |
| Net income 1 | 101.8 | 12.1 | 17.6 | 16.7 | 77.5 | 93.52 | 126.5 | 158 |
| Net Debt 1 | 489.3 | 890.9 | 944 | 1,158 | 1,357 | 776.3 | 784 | 808.2 |
| Reference price 2 | 36.13 | 12.54 | 13.50 | 16.75 | 20.39 | 24.01 | 24.01 | 24.01 |
| Nbr of stocks (in thousands) | 149,317 | 149,108 | 149,652 | 150,139 | 150,979 | 151,974 | - | - |
| Announcement Date | 2/11/22 | 2/17/23 | 2/9/24 | 2/12/25 | 2/10/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 38.88x | 1.75x | 10.69x | 0.93% | 4.1B | |
| 13.44x | 0.41x | 8.51x | 2.88% | 118B | |
| 15.49x | 1.9x | 9.49x | 0.68% | 99.34B | |
| -277.88x | 19.12x | -326.58x | -.--% | 56.71B | |
| 23.12x | 2.58x | 13.11x | 1.41% | 25.94B | |
| 22.82x | 2.1x | 12.02x | 0.92% | 25.79B | |
| 8.11x | 1.45x | 6.59x | -.--% | 21.52B | |
| 30.44x | 5.53x | 22.98x | 2.29% | 20.76B | |
| 19.57x | 1.76x | 8.84x | 3.55% | 18.25B | |
| 31.27x | 2.92x | 13.13x | 1.44% | 17.3B | |
| Average | -7.47x | 3.95x | -22.12x | 1.41% | 40.78B | |
| Weighted average by Cap. | -23.49x | 4.11x | -36.46x | 1.49% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MCOV B Stock
- Valuation Medicover AB
Select your edition
All financial news and data tailored to specific country editions
